284 related articles for article (PubMed ID: 12740532)
21. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
Lu S; Malice MP; Dass SB; Reiss TF
J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
[TBL] [Abstract][Full Text] [Related]
22. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis.
Pradalier A; Neukirch C; Dreyfus I; Devillier P
Allergy; 2007 Nov; 62(11):1331-4. PubMed ID: 17521311
[TBL] [Abstract][Full Text] [Related]
23. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
Nayak A; Langdon RB
Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
[TBL] [Abstract][Full Text] [Related]
24. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF;
Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
26. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
Goh BS; Ismail MI; Husain S
J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
[TBL] [Abstract][Full Text] [Related]
27. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
Wilson AM; Orr LC; Coutie WJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
29. The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis.
Lee DK; Haggart K; Currie GP; Anderson SD; Lipworth BJ
Br J Clin Pharmacol; 2003 Jun; 55(6):639-42. PubMed ID: 12814463
[TBL] [Abstract][Full Text] [Related]
30. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
[TBL] [Abstract][Full Text] [Related]
31. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
Horak F; Stübner P; Zieglmeyer R; Harris AG
Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
[TBL] [Abstract][Full Text] [Related]
33. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
34. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
35. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
Bachert C; van Cauwenberge P
Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
Chervinsky P; Nayak A; Rooklin A; Danzig M
Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
[TBL] [Abstract][Full Text] [Related]
37. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
Katial RK; Oppenheimer JJ; Ostrom NK; Mosnaim GS; Yancey SW; Waitkus-Edwards KR; Prillaman BA; Ortega HG
Allergy Asthma Proc; 2010; 31(1):68-75. PubMed ID: 20167147
[TBL] [Abstract][Full Text] [Related]
38. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
[TBL] [Abstract][Full Text] [Related]
39. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.
van Adelsberg J; Philip G; Pedinoff AJ; Meltzer EO; Ratner PH; Menten J; Reiss TF;
Allergy; 2003 Dec; 58(12):1268-76. PubMed ID: 14616102
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]